<DOC>
	<DOC>NCT00863460</DOC>
	<brief_summary>Purpose of the study : To evaluate the antitumoral effect of two therapeutic procedures and to evaluate their respective toxicity on the CNS.</brief_summary>
	<brief_title>Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Histopathologically or cytologically proven diagnostic of Primary CNS lymphoma All histological types of nonHodgkin's lymphoma, except MALT Age &gt; 18 and &lt; 60 ans. Negative for HIV, HCV and HBV Written informed consent Age &lt; 18 or &gt; 60 ans Isolated intraocular lymphoma Previous history of indolent lymphoma Previous chemotherapy or radiotherapy for PCNSL Isolated CNS relapse of systemic NHL Previous history of cancer in the last 5 years, except basocellular carcinoma and non invasive cervix cancer Renal insufficiency or creatinin clearance &lt; 60 ml/min Liver enzymes &gt; 3N. Platelets &lt; 100 000/mm3 or neutrophils &lt; 1500/mm3) Previous history of organ transplantation or other cause of severe immunodeficiency Pregnancy or active sexual women with no contraception Unable to follow the protocol for any reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>